
Cleveland Clinic researchers have designed a potential new class of drugs that may reduce the risk of cardiovascular disease by …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

